Some series of the Swiss drug “Diprospan” were withdrawn.
As reported in the center of analytical examination, the center withdrew the series U038559 with a date expiration date 10/2023, W002245 with a validity date of 11/2023, W009991 with the date of expiration of 01/2024, W015391 with the date of expiration of 03 /2024, W025079 with the date of expiration of 06/2024 and W033463 with the date of expiration of 08/2024, the Center for Medicines of the U038559 series with an expired 10/2023 shell containing 2.63 mg of suspension for injections of 1 ml, No. 5 In glass ampoules, in plastic packaging, in a cardboard box.
Based on the appeal about the voluntary review of the Swiss company Organon Central East GmbH, the indicated series of drugs, it was decided to review them, ban wholesale and retail sale and import.
This means that drugs released only with the indicated series of this drug are unsuitable for use.